Follows pregnant women taking pitolisant for narcolepsy and their babies
Tracks health of pregnant women using pitolisant, and their children.
Key facts
- Who runs it
- Harmony Biosciences Management, Inc.
- Where
- Morrisville, United StatesSee the site
- Trial code
- Registry title
- WAKIX® (Pitolisant) Pregnancy Registry
- Status
- Recruiting
- People taking part
- 1,329 people, planned
- Started
- 24 Aug 2021
- Expected to end
- 30 Jun 2030
- Type of study
- Observational, 5 groups
- Treatments tested
- Pitolisant
- Comparator Products
- Record updated
- 12 June 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for pregnant women in the US, with or without narcolepsy, to study how pitolisant use during pregnancy affects mothers and babies. It only observes; it gives no treatment.
- Age
- Any age.
- Sex
- Women only (pregnant women).
- Disease stage
- Women with narcolepsy (a sleep disorder) can join. Women without narcolepsy can join if they took pitolisant or a comparator product during pregnancy.
- Earlier treatment
- Women with narcolepsy can join if they had at least one dose of pitolisant or a comparator product during pregnancy, or neither. Women without narcolepsy must have had at least one dose of pitolisant or a comparator product during pregnancy.
Main reasons for not taking part
- The pregnancy already ended before first contact with the Registry Coordination Center.
This trial only enrols pregnant participants. The registry sentence this rests on: * Pregnant woman of any age
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Pregnant woman of any age
- Consent to participate
- Authorization for her HCP(s) to provide data to the registry
- For participants with a diagnosis of narcolepsy: exposure to at least one dose of pitolisant or one dose of a comparator product, or, unexposed to pitolisant or comparator products at any time during pregnancy (i.e., any pregnant woman with a diagnosis of narcolepsy)
- For participants without a diagnosis of narcolepsy: exposure to at least one dose of pitolisant or one dose of a comparator product at any time during pregnancy; Exclusion Criterion:
- Occurrence of pregnancy outcome prior to first contact with the Registry Coordination Center (RCC) (i.e., retrospectively enrolled)
Where in United States
- Evidera (PPD)Morrisville, United StatesContact: Marielle Bassell, BATaking people
About the trial
What the trial wants to find out
The WAKIX (pitolisant) Pregnancy Registry is a US-based, prospective, observational cohort study designed to evaluate the association between pitolisant exposure during pregnancy and subsequent maternal, fetal, and infant outcomes.
The 5 groups in the trial
- Pitolisant-exposed participants with narcolepsy
Pregnant women with a diagnosis of narcolepsy who are exposed to pitolisant at any time during pregnancy
Treatment: Pitolisant
- Unexposed participants with narcolepsy
Pregnant women with a diagnosis of narcolepsy who are not exposed to pitolisant or a comparator product at any time during pregnancy
- Comparator-exposed participants with narcolepsy
Pregnant women with a diagnosis of narcolepsy who are not exposed to pitolisant at any time during pregnancy but who are exposed to comparator products at any time during pregnancy
Treatment: Comparator Products
- Pitolisant-exposed participants without narcolepsy
Pregnant women without a diagnosis of narcolepsy who are exposed to pitolisant at any time during pregnancy
Treatment: Pitolisant
- Comparator-exposed participants without narcolepsy
Pregnant women without a diagnosis of narcolepsy who are not exposed to pitolisant at any time during pregnancy but who are exposed to a comparator product at any time during pregnancy
Treatment: Comparator Products
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- WAKIX® (Pitolisant) Pregnancy Registry: An Observational Study of the Safety of Pitolisant Exposure in Pregnant Women and Their Offspring
- Plain-language title
- Follows pregnant women taking pitolisant for narcolepsy and their babiesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 12 June 2026